Clinical Trials Logo

Critical Illness clinical trials

View clinical trials related to Critical Illness.

Filter by:

NCT ID: NCT04580680 Recruiting - Sepsis Clinical Trials

Extracorporeal Blood Purification Therapy in Critically Ill Patients (GlobalARRT)

GlobalARRT
Start date: November 1, 2020
Phase:
Study type: Observational [Patient Registry]

Worldwide, the use of Extracorporeal Blood Purification (EBP) in everyday clinical practice is becoming increasingly common, particularly in critical care settings. The efficacy of most of these treatments on removal of inflammatory mediators is the main rationale behind the use of EBP in critically ill patients with multiorgan dysfunction. Nonetheless, there are still some doubts as to the clinical efficacy of bacterial toxins and cytokines removal and many clinical trials aiming at exploring the effect of EBP on long-term outcomes of septic patients have failed to demonstrate consistent results regarding 28 day- or hospital-mortality rates. The primary aim of this observational prospective web-based registry is to define the possible clusters of critically ill patients - treated with extracorporeal blood purification therapies worldwide - who are homogeneous regarding both clinical and treatment characteristics and seem to benefit the most from EBP.

NCT ID: NCT04578886 Completed - Delirium Clinical Trials

The Effect of Guanfacine on Delirium in Critically Ill Patients

Start date: November 23, 2020
Phase: Phase 3
Study type: Interventional

Delirium in patients in the intensive care unit (ICU) is a common problem associated with increased mortality and morbidity, including increased hospital and ICU length of stay, greater hospital cost, increased ventilator days, and long-term cognitive disability. Various pharmacologic agents including dopamine antagonists, acetylcholinesterase inhibitors, melatonin, antipsychotics, alpha-2 agonists, and glutamate antagonists are used for treatment of delirium in the ICU despite the lack of clear evidence of efficacy.Since there is no evidence-based pharmacologic treatment of ICU delirium, current therapy is focused on non-pharmacologic prevention techniques and pharmacologic agents are used once delirium is established. Guanfacine, an alpha-2 agonist, has been identified as a potential medication that may be of benefit in the treatment of delirium. The purpose of this study to investigate the effects of guanfacine versus placebo on delirium in critically ill patients admitted to the ICU and to determine whether guanfacine along with standard of care reduces the duration of delirium, compared to standard of care alone.

NCT ID: NCT04577196 Not yet recruiting - Critical Illness Clinical Trials

Improving Situational Awareness Before Acute Care

IMPULSE
Start date: November 1, 2020
Phase:
Study type: Observational [Patient Registry]

This study aims to assess the impact on the trauma team's situational awareness of using a dashboard to synthesize and disseminate available information on a critical patient incoming to the trauma center.

NCT ID: NCT04576806 Withdrawn - Sepsis Clinical Trials

Physiological Effects of 38°C vs. 22°C Fluid Therapy in Critically Ill Patients

Start date: April 30, 2021
Phase: N/A
Study type: Interventional

A randomized controlled clinical trial. 24 adult ICU patients will be recruited upon decision to administer fluid bolus of 500ml of crystalloid. The fluid will then be randomized to be infused at controlled room temperature or warmed to body temperature. Hemodynamic measurements will be made for 2 hours following the bolus, and laboratory values will be noted. The hypothesis is that part of the hemodynamic response will differed in response to cooling, and be larger in the cold group.

NCT ID: NCT04576065 Completed - Critical Illness Clinical Trials

Wake Forest Post-ICU Telehealth (WFIT) Program

WFIT
Start date: March 19, 2021
Phase: N/A
Study type: Interventional

Wake Forest Post-Intensive Care Unit Telehealth (WFIT) program consists of a nurse practitioner who has access to daily activity data as well as telehealth capabilities for 6 months post-hospital discharge in order to improve the post-critical illness care of patients. The study team expects that this program will reduce costs to patients. Through this intervention the study team hopes to improve quality of life, patient satisfaction, reduce readmissions and ER visits, and reduce mortality. The study team will perform a formal randomized controlled trial with a cost-effectiveness analysis to demonstrate its value.

NCT ID: NCT04571554 Completed - Clinical trials for Temperature Monitoring

Accuracy of Infrared Thermography for Detecting Febrile Critically Ill Patients

Start date: October 1, 2020
Phase:
Study type: Observational

Accurate determination of critically ill patient of being febrile or not is an essential part of management critically ill patients as it prompt investigating the underlying cause and initiating therapeutic action. Pulmonary artery catheter thermistor is considered the gold standard for temperature measurement . Central non-vascular thermometer such as esophageal, bladder and rectal thermometer showed excellent correlation and agreement with pulmonary artery catheter thermistor and has been accepted as alternative methods for core body temperature assessment. However, those methods are invasive and cannot be tolerated in conscious patients. Peripheral thermometer such as oral, axillary and tympanic membrane thermometer are either impractical in unconscious patient and/or carry the risk of trauma and infection. Infrared thermography (IRT) is a non-contact and non-invasive imaging approach that enable real-time estimation of body temperature by detecting infrared emission. IRT had been used for screening for mass detection of febrile patients at airport at times of infectious disease outbreak. In adult population, IRT showed good accuracy in detecting febrile patients in emergency department; however, those studies used 37.7⁰ C as the fever threshold and the reference standard was either oral 6 or tympanic membrane thermometer. No studies to the best of our knowledge had evaluated the IRT accuracy in detecting fever in critically ill patients using esophageal thermometer as a reference method.

NCT ID: NCT04565613 Recruiting - Critically Ill Clinical Trials

Protein Supplementation vs Standard Feeds in Underweight Critically Ill Children: A Dual-Centre Pilot RCT

Start date: January 25, 2021
Phase: N/A
Study type: Interventional

This pilot trial is part of a long-term research program leading to a large trial to determine if a strategy of supplementing protein in a subset of critically ill children is superior to standard enteral nutrition care. The investigators hypothesize that protein supplementation to critically ill children with body mass index (BMI) z-score <0 reduces the length of stay in the paediatric intensive care unit (PICU) and hospital, as well as the duration of mechanical ventilation (MV).

NCT ID: NCT04565002 Recruiting - Clinical trials for ICU Acquired Weakness

Transcutaneous Electrical Diaphragmatic Stimulation in Critically Ill Elderly Patients

Start date: June 25, 2018
Phase: N/A
Study type: Interventional

Abstract..................................................................................... .....................04 Introduction................................................................................. ...................10 Methods...................................................................................... ...................14 Financial Support...................................................................................... .....22 References................................................................................... ..................24

NCT ID: NCT04555096 Terminated - Covid19 Clinical Trials

A Trial of GC4419 in Patients With Critical Illness Due to COVID-19

Start date: September 9, 2020
Phase: Phase 2
Study type: Interventional

A Trial of GC4419 in Patients with Critical Illness due to COVID-19

NCT ID: NCT04552834 Active, not recruiting - Critical Illness Clinical Trials

Alterations of the Microbiome During Critical Illness With Short and Long Term Clinical Outcomes

Start date: September 15, 2020
Phase:
Study type: Observational

This study is designed to study the variations in the microbiome among critically ill patients and the effect of admission to the medical intensive care unit (MICU) at the University of Chicago. Additionally, investigators will examine the downstream clinical effects of dysbiosis in ICU patients and how patients maybe effected long term.